₹1,562.00-11.10 (-0.71%)
04:01 PM, 16-Jan-2026₹1,558.50-12.10 (-0.77%)
03:47 PM, 16-Jan-2026BSE : 544210
NSE : EMCURE
Sector : Health care
ISIN Code : INE168P01015
Last Updated: 16-Jan-2026 | 04:01 PM IST
| Market Cap (₹ Cr) | 29,611 |
Traded Value (₹ Cr) | 2.14 |
Volume (Shares) | 13,677 |
Face Value (₹) | 10 |
52-Week High (₹) | 1,575.00 |
52-Week High Date | 14-Jan-2026 |
52-Week Low (₹) | 890.00 |
52-Week Low Date | 07-Apr-2025 |
All Time High (₹) | 1,577.50 |
All Time High Date | 18-Sep-2024 |
All Time Low (₹) | 890.00 |
All Time Low Date | 07-Apr-2025 |
| PARAMETER | VALUES |
|---|---|
| Market Cap (₹ Cr) | 29,544 |
| EPS - TTM (₹) [C] | 43.23 |
| P/E Ratio (X) [C] | 36.05 |
| Face Value (₹) | 10 |
| Latest Dividend (%) | 30.00 |
| Latest Dividend Date | 14-Aug-2025 |
| Dividend Yield (%) | 0.19 |
| Book Value Share (₹) [C] | 250.17 |
| P/B Ratio (₹) [C] | 6.23 |
| Scheme Name | Amount Invested (₹ Cr) | No Of Shares | Net Asset (%) |
|---|---|---|---|
| Nippon India Multi Cap Fund (G) | 277.18 | 20,31,343 | 0.55 |
| Nippon India Multi Cap Fund (IDCW) | 277.18 | 20,31,343 | 0.55 |
| Nippon India Multi Cap Fund (B) | 277.18 | 20,31,343 | 0.55 |
| Nippon India Multi Cap Fund - Direct (G) | 277.18 | 20,31,343 | 0.55 |
| Nippon India Multi Cap Fund - Direct (B) | 277.18 | 20,31,343 | 0.55 |
| Nippon India Multi Cap Fund - Direct (IDCW) | 277.18 | 20,31,343 | 0.55 |
| Aditya Birla SL ELSS Tax Saver Fund (G) | 184.20 | 13,49,941 | 1.19 |
| Aditya Birla SL ELSS Tax Saver Fund - Direct (G) | 184.20 | 13,49,941 | 1.19 |
| Nippon India Pharma Fund (G) | 101.84 | 7,46,337 | 1.23 |
| Nippon India Pharma Fund (Bonus) | 101.84 | 7,46,337 | 1.23 |
Load more
| Today's Low/High (₹) | 1,534.90 1,575.00 |
| Week Low/High (₹) | 1,468.10 1,575.00 |
| Month Low/High (₹) | 1,356.00 1,575.00 |
| Year Low/High (₹) | 889.00 1,575.00 |
| All time Low/High (₹) | 890.00 1,580.00 |
| Period | BSE | NSE | SENSEX | NIFTY |
|---|---|---|---|---|
| 1 Week | 1.19% | 1.16% | -0.01% | 0.04% |
| 1 Month | 12.91% | 12.82% | -1.31% | -0.64% |
| 3 Month | 15.62% | 15.42% | 0.12% | 0.43% |
| 6 Month | 14.27% | 14.39% | 1.13% | 1.91% |
| 1 Year | 12.45% | 12.36% | 8.47% | 10.22% |
| 3 Year | - | - | 39.07% | 43.59% |
Whole Time Director : MUKUND KESHAO GURJAR
Whole Time Director : SUNIL RAJNIKANT MEHTA
Managing Director & Chief Executive Officer : SATISH RAMANLAL MEHTA
Chairman (Non-Executive) : Berjis M Desai
Whole Time Director : NAMITA VIKAS THAPAR
Independent Director : P S Jayakumar
Independent Director : Vijay Gokhale
Independent Director : Vidya Rajiv Yeravdekar
Independent Director : Shailesh Ayyangar
Whole-time Director : SAMIT SATISH MEHTA
Registered Office: Plot # P-1 & P-2 IT BT Park, Phase II MIDC Hinjawadi,Pune,Maharashtra-411057 Ph: +91 20 3507 0033/+91 20 3507 0000
Email:investors@emcure.com
1. What's the Emcure Pharmaceuticals Ltd share price today?
Emcure Pharmaceuticals Ltd share price was Rs 1,562.00 at 04:01 PM IST on 16th Jan 2026. Emcure Pharmaceuticals Ltd share price was down by 0.71% from the previous closing price of Rs 1,573.10. Emcure Pharmaceuticals Ltd share price trend:
2. How can I quickly analyse the performance of the Emcure Pharmaceuticals Ltd stock?
The performance of the Emcure Pharmaceuticals Ltd stock can be quickly analysed on the following metrics:
3. What is the market cap of Emcure Pharmaceuticals Ltd?
Emcure Pharmaceuticals Ltd has a market capitalisation of Rs 29,611 crore.
4. What is Emcure Pharmaceuticals Ltd's 52-week high/low share price?
The Emcure Pharmaceuticals Ltd’s 52-week high share price is Rs 1,575.00 and 52-week low share price is Rs 890.00.
5. Is the Emcure Pharmaceuticals Ltd profitable?
On a consolidated basis, Emcure Pharmaceuticals Ltd reported a profit of Rs 251.37 crore on a total income of Rs 2,272.95 crore for the quarter ended 2025.
6. Which are Emcure Pharmaceuticals Ltd’s peers in the Health care sector?
Emcure Pharmaceuticals Ltd’s top 5 peers in the Health care sector are Anthem Bioscienc, Ajanta Pharma, J B Chemicals &, Emcure Pharma, Gland Pharma, Wockhardt, Piramal Pharma.
7. Who owns how much in Emcure Pharmaceuticals Ltd?
Key changes to the Emcure Pharmaceuticals Ltd shareholding are as follows: